Crossmark

Iode 123-FP-CIT versus 18-fluoro L-DOPA : avantages et inconvénients

Crossref DOI link: https://doi.org/10.1016/j.mednuc.2014.03.117

Published Print: 2014-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chan Hew Wai, A.

Camps, E.

Bonan, B.
More Information

This article is maintained by: Elsevier

Article Title: Iode 123-FP-CIT versus 18-fluoro L-DOPA : avantages et inconvénients

Journal Title: Médecine Nucléaire

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.mednuc.2014.03.117

Content Type: simple-article

Copyright: Copyright © 2014 Published by Elsevier Masson SAS